[17] This recommendation was based on three Phase III randomized controlled trials in which dolutegravir 50 mg once daily plus two nucleoside reverse transcriptase inhibitors (NRTIs) were compared ...

When dolutegravir 50 mg twice daily was given with methadone, there were no changes observed in methadone AUC. The combination was well tolerated and no adverse effects were reported. Therefore ...